TH17 cells are able to promote tumor cell growth by secreting IL-17, IL-23, and CCL20 (Wu H.H. et al., 2015), and inhibit the CD8+ T-mediated immune response by IL-17 and IL-22 (Yan and Richmond, 2020). The gene discussed is IL17A; the disease is neoplasm.